Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-031299

President sold 50,000 shares at $65.00 ($3,250,000)

From the SEC's structured data for this filing

Trades in this filing

Novak Rodger · President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-05-19 Sale : show line 1 in the form −50,000 $65.00 $3,250,000 798,007 D
Open-market sales · 50,000 sh · avg $65.00 · $3,250,000
Loading xslF345X03/doc4.xml…